Harbour BioMed

Harbour BioMed Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 71
Employees
  • Latest Deal Type
  • Series C
  • Latest Deal Amount
  • $103M
Latest Deal Amount
  • Investors
  • 18

Harbour BioMed General Information

Description

Developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1 Broadway, 14th Floor
  • Cambridge, MA 02142
  • United States
+1 (617) 000-0000

Harbour BioMed Timeline

2017201820192020
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Harbour BioMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series C) 09-Jul-2020 $103M 00000 Completed Generating Revenue
4. Early Stage VC (Series B1) 12-Mar-2020 0000 00000 Completed Clinical Trials - General
3. Early Stage VC (Series B) 26-Aug-2018 0000 00000 Completed Clinical Trials - General
2. Early Stage VC 22-Jan-2018 $50M Completed Startup
1. Early Stage VC (Series A) 01-Dec-2016 $50M $50M Completed Startup

Harbour BioMed Competitors (36)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
BioAtla Venture Capital-Backed San Diego, CA 00 000.00 00000 00000 000.00
000000 Formerly PE-Backed Paris, France 00 000.00 000000000 000.00
000000 00000000000 Corporation PA 000 000.00 00000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
000000000 00000000 Venture Capital-Backed Rockville, MD 000.00 0000000000 0 000.00

Harbour BioMed Executive Team (8)

Name Title Board Seat Contact Info
Jingsong Wang MD Co-Founder, Chairman & Chief Executive Officer
Atul Deshpande Ph.D Chief Strategy Officer & Head of US Operations
Xiaoxiang Chen MD Chief Development Officer
Mai-Jing Liao Ph.D Chief Business Officer
George Liu Ph.D Vice President & Head of Early Development and Scientific Operation

1 Former Executive

Harbour BioMed Board Members (1)

Name Representing Role Since
Jingsong Wang MD Harbour BioMed Co-Founder, Chairman & Chief Executive Officer 000 0000

Harbour BioMed Investors (18)

To view Harbour BioMed‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Country Garden Venture Capital Corporate Venture Capital Minority 000 0000 000000 0
Hudson Bay Capital Management Hedge Fund Minority 000 0000 000000 0
Octagon Capital Group Venture Capital Minority 000 0000 000000 0
OrbiMed PE/Buyout Minority 000 0000 000000 0
Sage Partners Corporation Minority 000 0000 000000 0

Harbour BioMed Acquisitions (1)

To view Harbour BioMed‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 0000000000 19-Dec-2016 000000000000000000 Biotechnology 00000000 0000 00

Ready to get started?

Request a free trial

Harbour BioMed Subsidiaries (1)

Company Name Industry Location Founded
0000000 0000000000 Biotechnology 0000